Search Results 221-230 of 16351 for immunothérapie Bylaska
Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell malignancies ...
Immunotherapy with trastuzumab, pertuzumab, and atezolizumab, may induce changes in body's immune system and may interfere with the ability of tumor cells ...
These include targeted therapy, immunotherapy, CAR-T cell therapy, stem cell transplantation and clinical trials. Your care team works with you to ...
... with recurrent optic neuritis. B2 and B4. Improvement of the left optic nerve lesions is visible four months later, after immunotherapy. Share · Tweet ...
Evaluation of Outcomes in Metastatic Gastric and Esophageal Carcinoma in Relation to Immunotherapy. Rochester, Minn. The purpose of this study is: To assess ...
Participation eligibility · Recent therapeutic interventions within 3 (chemotherapy/radiotherapy) to 10 weeks (immunotherapy) · Prior treatment with ibrutinib or ...
... immunotherapy for patients who have stage IV metastatic melanoma. Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory ...
This open-label, exploratory study is designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or combinations ...
Duvelisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.